benoxaprofen has been researched along with cysteine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cassidy, MR; Drew, R; Knights, KM; Ryall, RG | 1 |
| Anderson, R; Eftychis, H | 1 |
1 review(s) available for benoxaprofen and cysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for benoxaprofen and cysteine
| Article | Year |
|---|---|
Interaction of benoxaprofen with rat erythrocytes: effects on oxidative metabolism and membrane ATPase activities.
Topics: Adenosine Triphosphatases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cysteine; Erythrocyte Membrane; Erythrocytes; Male; Oxidation-Reduction; Propionates; Rats; Rats, Inbred Strains | 1986 |
Prevention of induction of suppressor activity in human mononuclear leukocytes by ascorbate and cysteine in vitro.
Topics: Anti-Inflammatory Agents; Ascorbic Acid; Concanavalin A; Cysteine; Humans; Lymphocyte Activation; Lymphocytes; Oxidation-Reduction; Propionates; T-Lymphocytes, Regulatory | 1983 |